| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 07/03/2002 | EP1218494A2 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 07/03/2002 | EP1218491A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 07/03/2002 | EP1218414A2 Polypeptides for detection and elimination of ca19-9 antigen positive cells |
| 07/03/2002 | EP1218413A2 Engineering antibodies that bind irreversibly |
| 07/03/2002 | EP1218412A2 Human g-protein coupled receptor |
| 07/03/2002 | EP1218409A2 Factor-h related protein 5 (fhr-5) and antibodies thereto |
| 07/03/2002 | EP1218408A1 32 human secreted proteins |
| 07/03/2002 | EP1218406A1 Nucleic acids and secreted polypeptides encoded thereby |
| 07/03/2002 | EP1218397A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 07/03/2002 | EP1218036A1 Cell based assay |
| 07/03/2002 | EP1201758A9 Microorganisms and method for L-arginine production by fermentation |
| 07/03/2002 | EP1066393B1 Expression system for producing proteins |
| 07/03/2002 | EP1030690B1 Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype |
| 07/03/2002 | EP0892854B1 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 07/03/2002 | EP0578746B1 GENES WHICH INFLUENCE $i(PICHIA) PROTEOLYTIC ACTIVITY, AND USES THEREFOR |
| 07/03/2002 | CN1357049A Receptor based antagonists and mehtods of making and using |
| 07/03/2002 | CN1357046A Chitinase chitin-binding fragments |
| 07/03/2002 | CN1357045A Outer surface proteins, their genes, and their use |
| 07/03/2002 | CN1357043A Avirulent xanthomonas-campestris strains producing xanthan |
| 07/03/2002 | CN1357042A Interleukin-17 related mammalian cytokines, polynucleotides encoding them. uses |
| 07/03/2002 | CN1357041A Head trauma induced cytoplasmatic calcium binding protein |
| 07/03/2002 | CN1357040A Regulation of viral gene expression |
| 07/03/2002 | CN1357038A Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions |
| 07/03/2002 | CN1357037A Method for preservation of biological-active material |
| 07/03/2002 | CN1357009A Humanized antibody specific for human 4-1BB and pharmaceutical compsn comprising same |
| 07/03/2002 | CN1357008A Method for stabilising proteins in complex mixtures during thier storage in aqueous solvents |
| 07/03/2002 | CN1357005A Process for partitioning of proteins |
| 07/03/2002 | CN1356388A Transgenic saline algae bio-reactor |
| 07/02/2002 | US6414130 Polypeptides binds to extracellular domain, glycosylated polypeptide or monoclonal antibody; antitumor agents |
| 07/02/2002 | US6414129 Cells containing expression vectors; diagnosis; immunomodulator detection; genetic engineering |
| 07/02/2002 | US6414117 Compositions and methods for the treatment and diagnosis of immune disorders |
| 07/02/2002 | US6414115 Parasitic nematode transglutaminase proteins and uses thereof |
| 07/02/2002 | US6413933 Growth factor HTTER36 |
| 07/02/2002 | US6413776 High throughput screening of gene function using adenoviral libraries for functional genomics applications |
| 07/02/2002 | US6413770 NL4 tie ligand homologue nucleic acid |
| 07/02/2002 | US6413768 Maintenance system; plasmid has restricted copy number origin of replication with transcriptional terminators, a selection marker, a post-segregational killing system, and an inducible promoter |
| 07/02/2002 | US6413764 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof |
| 07/02/2002 | US6413763 Method of removing gas from a site using gas vesicles of cells |
| 07/02/2002 | US6413762 Viral nucleotide sequences |
| 07/02/2002 | US6413759 Streptokinase mutants |
| 07/02/2002 | US6413758 Dna for enzyme isolated from bacillus pumilus; for genetic engineering |
| 07/02/2002 | US6413756 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/02/2002 | US6413752 Protein capable of catalyzing transamination stereoselectively, gene encoding said protein and use thereof |
| 07/02/2002 | US6413746 Producing immunoglobulin by culturing animal hybridoma cells in presence of alkanoic acid or salt at concentration of 0.1 to 200 mm which enhances protein production but does not affect cell growth, accumulating, and recovering protein |
| 07/02/2002 | US6413742 Culturing recombinant host cell having dna which codes for fibrillar collagen monomer lacking a c propeptide sequence selection and alignment domain, then producing fibrillar collagen |
| 07/02/2002 | US6413740 Nucleic acid which codes for muscle specific kinase c-terminal fragment of human agrin; diagnosis and treatment of muscle disorders and neuromusclar disorders |
| 07/02/2002 | US6413738 House dust mite allergen, Der f VII, and uses therefor |
| 07/02/2002 | US6413736 Extending maturation phase of fermentation by exposure to low intensity light; slow feeding of rapidly metabolized glucose |
| 07/02/2002 | US6413731 Methods of screening for compounds which bind to a human SNORF36A receptor |
| 07/02/2002 | US6413726 Antibodies that specifically bind Cytostatin III |
| 07/02/2002 | US6413721 Methods of isolating common and specific antigens from excretory-secretory products of protostrongylidae |
| 07/02/2002 | US6413559 Baked goods |
| 07/02/2002 | US6413524 spsA polynucleotides and polypeptides |
| 07/02/2002 | US6413522 Papilloma viruses, products for the detection thereof as well as for treating diseases caused by them |
| 07/02/2002 | US6413518 Immunologically significant herpes simplex virus antigens and methods for identifying and using same |
| 07/02/2002 | US6413514 Methods of using antibodies against human CD40 |
| 07/02/2002 | CA2253080C 5-substituted picolinic acid compounds and their production process |
| 07/02/2002 | CA2184908C Human osteoclast-derived cathepsin |
| 07/02/2002 | CA2165839C Thermostable xylanase |
| 07/02/2002 | CA2159083C Recombinant .alpha.-n-acetylgalactosaminidase enzyme and cdna encoding said enzyme |
| 07/02/2002 | CA2083172C Protein d - an igd-binding protein of haemophilus influenzae |
| 07/02/2002 | CA2080008C Water-soluble mutein of fibroblast growth factor (fgf) receptor |
| 07/02/2002 | CA2054699C Growth of vascular endothelial cell growth factor and dna encoding same |
| 07/02/2002 | CA2050749C Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations |
| 07/02/2002 | CA1341372C Hybrid dna synthesis of insulin |
| 06/27/2002 | WO2002050311A2 Lactobacillus strain producing levan and its use in human or pet food products |
| 06/27/2002 | WO2002050309A2 A bardet-biedl susceptibility gene and uses thereof |
| 06/27/2002 | WO2002050290A1 A yeast expression vector and a method of making a recombinant protein by expression in a yeast cell |
| 06/27/2002 | WO2002050287A2 Multifunctional protease inhibitors and their use in treatment of disease |
| 06/27/2002 | WO2002050286A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 06/27/2002 | WO2002050285A2 Histone deacetylase-related gene and protein |
| 06/27/2002 | WO2002050284A2 Oxidoreductases |
| 06/27/2002 | WO2002050283A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 06/27/2002 | WO2002050282A1 Novel thermostable galactose isomerase and tagatose production thereby |
| 06/27/2002 | WO2002050279A2 Nucleic acid-associated proteins |
| 06/27/2002 | WO2002050276A2 Proteins and nucleic acids encoding same |
| 06/27/2002 | WO2002050275A2 Proteins and nucleic acids encoding same |
| 06/27/2002 | WO2002050272A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 06/27/2002 | WO2002050270A1 Novel tissue-specific secretory polypeptide and dna thereof |
| 06/27/2002 | WO2002050262A2 Mutant mycobacteria for use in therapy |
| 06/27/2002 | WO2002050260A2 Process for the production and purification of secreted proteins ans the production of arrays of proteins |
| 06/27/2002 | WO2002050258A1 Novel aggrecanase |
| 06/27/2002 | WO2002050255A2 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof |
| 06/27/2002 | WO2002050252A2 Method for generating competent or transformed cells |
| 06/27/2002 | WO2002050122A2 Means for the diagnosis and therapy of ctcl |
| 06/27/2002 | WO2002050120A2 High affinity antibodies |
| 06/27/2002 | WO2002050118A2 Single-strand antibody with improved stability |
| 06/27/2002 | WO2002050117A2 G-proteins coupled receptor proteins and nucleic acids encoding same |
| 06/27/2002 | WO2002050115A1 Modified tachykinin receptors |
| 06/27/2002 | WO2002050113A2 Interleukin-1 related gene and protein |
| 06/27/2002 | WO2002050107A2 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/27/2002 | WO2002050106A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4 |
| 06/27/2002 | WO2002050105A1 Novel compounds |
| 06/27/2002 | WO2002050104A2 Methods and cells for detecting modulators of rgs proteins |
| 06/27/2002 | WO2002050096A1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | WO2002049971A1 Microbiological composition |
| 06/27/2002 | WO2002049666A2 Mycoplasma hyopneumoniae bacterin vaccine |
| 06/27/2002 | WO2002049661A1 Preventievs/remedies for diabetes and functional foods containing the same |
| 06/27/2002 | WO2002049625A2 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 06/27/2002 | WO2002049441A2 Liquid yeast compositions |